When tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was discovered in 1995, many studies were performed to demonstrate that it selectively induces apoptosis in tumor cells in vivo25–27. The gene discussed is TNFSF10; the disease is neoplasm.